Reyataz and Deafness - from FDA reports

Deafness is found among people who take Reyataz, especially for people who are male, 40-49 old also take medication Norvir, . This review analyzes which people have Deafness with Reyataz. It is created by eHealthMe based on reports of 8,570 people who have side effects when taking Reyataz from FDA , and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.

On Apr, 24, 2018

8,570 people reported to have side effects when taking Reyataz.
Among them, 9 people (0.11%) have Deafness

Number of reports submitted per year:

Could Reyataz cause Deafness?

Gender of people who have Deafness when taking Reyataz *:

  • female: 14.29 %
  • male: 85.71 %

Age of people who have Deafness when taking Reyataz *:

  • 0-1: 28.57 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 57.14 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top co-used drugs for these people *:

  • Truvada: 3 people, 33.33%
  • Norvir: 3 people, 33.33%
  • Zerit: 1 person, 11.11%
  • Efavirenz: 1 person, 11.11%
  • Combivir: 1 person, 11.11%

Top other side effects for these people *:

  • Otosalpingitis (a eustachian tube inflammation): 1 person, 11.11%
  • Low Birth Weight Baby: 1 person, 11.11%
  • Hair Loss: 1 person, 11.11%
  • Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you take Reyataz and have Deafness?

Related studies


Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,725 users)


Deafness has been reported by people with osteoporosis, rheumatoid arthritis, high blood pressure, multiple sclerosis, high blood cholesterol (latest reports from 13,837 Deafness patients).

Drugs that are associated with Deafness
Deafness (2,043 drugs)
Could your condition cause Deafness
Deafness (1,767 conditions)
Expand the study to include all drugs with the same ingredients
Deafness and drugs with ingredients of atazanavir sulfate.
Expand the study to include reports from both FDA and eHealthMe
Deafness and Reyataz from FDA and eHealthMe reports
Reyataz side effects
Browse all side effects of Reyataz
a b c d e f g h i j k l m n o p q r s t u v w x y z

Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

What would happen?

Predict new side effects and undetected conditions when you take Reyataz and have Deafness

You are not alone. Join our personalized support groups:

Can you answer these questions

More questions for: Reyataz, Deafness

You may be interested in these posts

More posts for: Reyataz, Deafness

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.